{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:19:19Z","timestamp":1790630359263,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":3386,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.bbmt.2005.09.010","type":"journal-article","created":{"date-parts":[[2006,1,8]],"date-time":"2006-01-08T07:08:10Z","timestamp":1136704090000},"page":"102-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Can Only Partial T-Cell Depletion of the Graft before Hematopoietic Stem Cell Transplantation Mitigate Graft-versus-Host Disease While Preserving a Graft-versus-Leukemia Reaction? A Prospective Phase II Study"],"prefix":"10.1016","volume":"12","author":[{"given":"Yves","family":"Chalandon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy","family":"Roosnek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Mermillod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Waelchli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Helg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Chapuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2005.09.010_bib1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1056\/NEJM199403243301206","article-title":"Bone marrow transplantation","volume":"330","author":"Armitage","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2005.09.010_bib2","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation","volume":"6","author":"Bearman","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.09.010_bib3","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1182\/blood.V77.8.1660.1660","article-title":"Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase","volume":"77","author":"Clift","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib4","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/blood.V76.9.1867.1867","article-title":"Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission","volume":"76","author":"Clift","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood.V82.2.677.677","article-title":"Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome","volume":"82","author":"Anderson","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib6","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V83.9.2723.2723","article-title":"A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia","volume":"83","author":"Ringden","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1182\/blood.V84.3.941.941","article-title":"Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia","volume":"84","author":"Storb","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib8","first-page":"415","article-title":"Bone marrow transplantation for primary refractory acute leukaemia","volume":"14","author":"Mehta","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.09.010_bib9","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1182\/blood.V88.12.4711.bloodjournal88124711","article-title":"Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma","volume":"88","author":"Bjorkstrand","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib10","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1182\/blood.V89.8.3039","article-title":"CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission","volume":"89","author":"Soiffer","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib11","first-page":"499","article-title":"Autologous bone marrow transplantation for acute myeloid leukemia in first remission","volume":"16","author":"Mehta","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.09.010_bib12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJM199103073241005","article-title":"Graft-versus-host disease","volume":"324","author":"Ferrara","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2005.09.010_bib13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(84)92848-4","article-title":"Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients","volume":"1","author":"Prentice","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2005.09.010_bib14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0140-6736(84)92564-9","article-title":"Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1)","volume":"2","author":"Waldmann","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2005.09.010_bib15","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V66.3.664.664","article-title":"Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts","volume":"66","author":"Martin","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib16","first-page":"445","article-title":"Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants","volume":"3","author":"Martin","year":"1988","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.09.010_bib17","doi-asserted-by":"crossref","first-page":"806","DOI":"10.7326\/0003-4819-108-6-806","article-title":"Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion","volume":"108","author":"Goldman","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2005.09.010_bib18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.1999.17.2.561","article-title":"Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia","volume":"17","author":"Sehn","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.09.010_bib19","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1182\/blood.V92.12.4581","article-title":"Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection","volume":"92","author":"Hale","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib20","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood.V85.6.1659.bloodjournal8561659","article-title":"Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma","volume":"85","author":"Korbling","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib21","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood.V85.6.1655.bloodjournal8561655","article-title":"Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor","volume":"85","author":"Bensinger","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib22","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood.V85.6.1666.bloodjournal8561666","article-title":"Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor)","volume":"85","author":"Schmitz","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib23","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1182\/blood.V88.7.2794.bloodjournal8872794","article-title":"Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies","volume":"88","author":"Bensinger","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib24","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/sj.bmt.1701234","article-title":"Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia","volume":"21","author":"Schmitz","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.09.010_bib25","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(00)02090-0","article-title":"Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases","volume":"355","author":"Powles","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2005.09.010_bib26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.2000.18.3.537","article-title":"Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia","volume":"18","author":"Blaise","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.09.010_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","article-title":"Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers","volume":"344","author":"Bensinger","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2005.09.010_bib28","first-page":"3702","article-title":"Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT)","volume":"95","author":"Champlin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood-2001-12-0304","article-title":"Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia","volume":"100","author":"Schmitz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib30","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood-2002-01-0048","article-title":"A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies","volume":"100","author":"Couban","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib31","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1200\/JCO.2002.12.049","article-title":"Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia","volume":"20","author":"Ringden","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.09.010_bib32","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood.V98.10.2900","article-title":"Peripheral blood stem cell versus bone marrow allotransplantation","volume":"98","author":"Korbling","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib33","first-page":"813","article-title":"Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1","volume":"186","author":"Slavin","year":"1985","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.bbmt.2005.09.010_bib34","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00007890-198804000-00018","article-title":"T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation","volume":"45","author":"Hale","year":"1988","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2005.09.010_bib35","first-page":"305","article-title":"Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection","volume":"17","author":"Hale","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.09.010_bib36","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2141.1995.tb08356.x","article-title":"T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor\u2019s peripheral blood lymphocytes for prevention of relapse","volume":"89","author":"Naparstek","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2005.09.010_bib37","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0301-472X(99)00052-1","article-title":"Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies","volume":"27","author":"Naparstek","year":"1999","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2005.09.010_bib38","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/sj.bmt.1703024","article-title":"Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation","volume":"27","author":"Barge","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.09.010_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2141.2003.04228.x","article-title":"T-cell depletion with Campath-1H \u201cin the bag\u201d for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft-versus-host disease, rapid immune constitution and improved survival","volume":"121","author":"Chakrabarti","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2005.09.010_bib40","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0360-3016(00)01491-7","article-title":"Total body irradiation before allogeneic bone marrow transplantation","volume":"49","author":"Bieri","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bbmt.2005.09.010_bib41","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1182\/blood.V96.7.2419","article-title":"In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation","volume":"96","author":"Kottaridis","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib42","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood.V76.5.1037.1037","article-title":"What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?","volume":"76","author":"Storb","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJM198603203141201","article-title":"Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia","volume":"314","author":"Storb","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2005.09.010_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2005.09.010_bib45","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1182\/blood.V86.7.2815.2815","article-title":"Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation","volume":"86","author":"Einsele","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib46","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1182\/blood.V79.11.2834.bloodjournal79112834","article-title":"Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin","volume":"79","author":"Attal","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib47","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","article-title":"Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation","volume":"10","author":"Chalandon","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.09.010_bib48","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2005.09.010_bib49","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00007890-199408000-00004","article-title":"Graft-versus-myeloid leukemia responses following syngeneic and allogeneic bone marrow transplantation","volume":"58","author":"Korngold","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2005.09.010_bib50","first-page":"445","article-title":"The role of CD4 and CD8 T cells in the graft-versus-leukemia response in Rauscher murine leukemia","volume":"8","author":"OKunewick","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.09.010_bib51","first-page":"51","article-title":"Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow","volume":"8","author":"Truitt","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.09.010_bib52","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood.V68.3.770.770","article-title":"Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease","volume":"68","author":"Kernan","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib53","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1182\/blood.V83.10.3090.3090","article-title":"Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft","volume":"83","author":"Verdonck","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib54","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0301-472X(03)00195-4","article-title":"A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies","volume":"31","author":"Cornelissen","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2005.09.010_bib55","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1182\/blood.V85.11.3302.bloodjournal85113302","article-title":"Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease","volume":"85","author":"Johnson","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib56","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1182\/blood-2002-09-2687","article-title":"Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations","volume":"102","author":"Morris","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib57","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/sj.leu.2402203","article-title":"Induction of graft-versus-leukemia to prevent relapse after partially lymphocyte-depleted allogeneic bone marrow transplantation by pre-emptive donor leukocyte infusions","volume":"15","author":"Schaap","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2005.09.010_bib58","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.bmt.1701131","article-title":"T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect","volume":"21","author":"Barrett","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.09.010_bib59","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJM198903303201303","article-title":"Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms","volume":"320","author":"Sullivan","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2005.09.010_bib60","first-page":"591","article-title":"Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia","volume":"15","author":"Mackinnon","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.09.010_bib61","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood.V82.8.2310.2310","article-title":"Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation","volume":"82","author":"Drobyski","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib62","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","article-title":"Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia","volume":"86","author":"Kolb","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.09.010_bib63","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879105006749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879105006749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:25:07Z","timestamp":1761056707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879105006749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S1083879105006749"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2005.09.010","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can Only Partial T-Cell Depletion of the Graft before Hematopoietic Stem Cell Transplantation Mitigate Graft-versus-Host Disease While Preserving a Graft-versus-Leukemia Reaction? A Prospective Phase II Study","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2005.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}